Cargando…

1334. Performance of C-Reactive Protein and Procalcitonin in Immunocompromised Children with SIRS

BACKGROUND: Biomarkers (C-reactive protein [CRP], procalcitonin [PCT]) have been used in patients with systemic inflammatory response syndrome (SIRS) to identify those with and without bacterial infection. However, their performance in immunocompromised (IC) children is not well studied. METHODS: Re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Posch, Leila C, Boge, Craig L K, Gerber, Jeffrey, Fitzgerald, Julie, Weiss, Scott L, Lautenbach, Ebbing, Coffin, Susan E, Downes, Kevin J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808702/ http://dx.doi.org/10.1093/ofid/ofz360.1198

Ejemplares similares

Implementation of a Pragmatic Biomarker-Driven Algorithm to Guide Antibiotic Use in the Pediatric Intensive Care Unit: the Optimizing Antibiotic Strategies in Sepsis (OASIS) II Study
por: Downes, Kevin, et al.
Publicado: (2017)

1334 Randomized Clinical Trial of Viral Testing and Serum Procalcitonin to Reduce Antibiotic Use for Respiratory Infections
por: Branche, Angela, et al.
Publicado: (2014)

1334. Radiographic Features Associated with Increased Microbiology Culture Yields in Pediatric Orbital Cellulitis
por: Cirks, Blake T, et al.
Publicado: (2022)

run 1334 MP, Ring 2 Momentum Blow-up During Acceleration
por: Dahlerup-Petersen, K, et al.
Publicado: (1983)

P1334: THE IMPACT OF SMALL MOLECULE INHIBITION OF METTL3 ON NORMAL HAEMATOPOIESIS
por: Sturgess, Katherine, et al.
Publicado: (2023)

Diagnostic accuracy of procalcitonin in critically ill immunocompromised patients
por: Bele, Nicolas, et al.
Publicado: (2011)

Procalcitonin as a marker of bacterial sepsis in immunocompromised patients
por: Gatserelia, Lana, et al.
Publicado: (2012)

639. Short Course Therapy for Urinary Tract Infections (SCOUT) in Children
por: Zaoutis, Theoklis, et al.
Publicado: (2020)

Combination of C-Reactive Protein and Procalcitonin in Distinguishing Fungal from Bacterial Infections Early in Immunocompromised Children
por: Liu, Yingli, et al.
Publicado: (2022)

1334. A Qualitative Assessment of Drivers of Antimicrobial Prescribing for Pediatric Patients in Diverse Ambulatory Settings
por: Spencer, Hillary, et al.
Publicado: (2020)

Procalcitonin and C-Reactive Protein/Procalcitonin Ratio as Markers of Infection in Patients With Solid Tumors
por: Vassallo, Matteo, et al.
Publicado: (2021)

P1334: THE IMPACT OF IMMUNOSUPPRESSION ON RECONSTITUTION OF CMV-SPECIFIC T CELLS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Dmitrova, A., et al.
Publicado: (2022)

1396. Live Virus Vaccination Following Pediatric Liver Transplantation: Results from Two Academic Children’s Hospitals
por: Newman, Alexander M, et al.
Publicado: (2020)

Procalcitonin is a good marker for the diagnosis of infection and the severity of illness in patients with SIRS
por: Endo, S, et al.
Publicado: (1999)

Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis and septic shock
por: Brunkhorst, FM, et al.
Publicado: (1999)

1402. Cystatin C Improves Estimation of Vancomycin Clearance in Critically Ill Children Using a Population Pharmacokinetic Modeling Approach
por: Downes, Kevin, et al.
Publicado: (2018)

Challenges in Treating Secondary Syphilis Osteitis in an Immunocompromised Patient with a Penicillin Allergy: Case Report and Review of the Literature
por: Ali, Robert, et al.
Publicado: (2016)

1744. CMV Infection and Management Among Pediatric Solid-Organ Transplant Recipients
por: Sharova, Anna, et al.
Publicado: (2019)

A boy with 13.34-Mb interstitial deletion of chromosome 4p15: A new case report and review of the literature
por: Mitroi, Anca Florentina, et al.
Publicado: (2017)

A new diagnostic and severity marker in patients with SIRS, sepsis, severe sepsis and septic shock; procalcitonin
por: Çelebi, S, et al.
Publicado: (2000)

Procalcitonin (PCT) for monitoring ICU patients with severe polytrauma and early SIRS: results of a prospective study
por: Stiletto, RJ, et al.
Publicado: (1998)

Evaluation of Plasmatic Procalcitonin in Healthy, and in Systemic Inflammatory Response Syndrome (SIRS) Negative or Positive Colic Horses
por: Nocera, Irene, et al.
Publicado: (2021)

1104. Comparison of Antibiotic Sampling Techniques: Predicting Plasma Vancomycin Concentrations Using Volumetric Absorptive Microsampling (VAMS) from Capillary and Venous/Arterial Whole Blood
por: Downes, Kevin J, et al.
Publicado: (2021)

C-reactive protein and procalcitonin in patients with DRESS syndrome
por: Taegtmeyer, Anne, et al.
Publicado: (2014)

1334. Amino Acid Sequence Diversity of HIV-1 Viral Proteins Tat and Vpr in South African People Living with HIV: Implications for Neurocognitive Function
por: Williams, Monray E
Publicado: (2023)

Fluoroquinolone-resistant Escherichia coli Carriage in Long-Term Care Facility
por: Maslow, Joel N., et al.
Publicado: (2005)

279 Prevalence and Epidemiology of Mupirocin Resistance Among Those Colonized with Methicillin-resistant Staphylococcus aureus in the Community
por: Cluzet, Valerie C., et al.
Publicado: (2014)

Correlation of endotoxin, procalcitonin and C-reactive peptide patterns with ICU admission
por: Otero, R, et al.
Publicado: (2008)

1335. A Translational Nephrotoxicity Model to Probe Acute Kidney Injury with Vancomycin and Piperacillin–Tazobactam
por: Pais, Gwendolyn M, et al.
Publicado: (2019)

2848. Risk factors for recurrence of community-onset urinary tract infections caused by extended spectrum cephalosporin-resistant Enterobacterales
por: Zhang, Helen L, et al.
Publicado: (2023)

Discrepancy of C-Reactive Protein, Procalcitonin and Interleukin-6 at Hospitalization: Infection in Patients with Normal C-Reactive Protein, Procalcitonin and High Interleukin-6 Values
por: Lee, Eun-Hwa, et al.
Publicado: (2022)

CRISPR-Cas9 correction of OPA1 c.1334G>A: p.R445H restores mitochondrial homeostasis in dominant optic atrophy patient-derived iPSCs
por: Sladen, Paul E., et al.
Publicado: (2021)

Automated Laboratory Reporting of Infectious Diseases in a Climate of Bioterrorism
por: M’ikanatha, Nkuchia M., et al.
Publicado: (2003)

344 Risk Factors for Infection with Escherichia coli among Long-Term Care Facility Residents with Gastrointestinal Tract Colonization with Fluoroquinolone-Resistant E. coli
por: Manning, Sara, et al.
Publicado: (2014)

Procalcitonin, cytokines and C-reactive protein in systemic inflammatory response
por: Tesinsky, P, et al.
Publicado: (1998)

C-reactive protein and procalcitonin in septic and HIV infection patients
por: Silva, JM, et al.
Publicado: (2009)

Procalcitonin and C-reactive protein in urinary tract infection diagnosis
por: Xu, Rui-Ying, et al.
Publicado: (2014)

Procalcitonin and C-reactive protein in differantiating to contamination from bacteremia
por: Oksuz, Lutfiye, et al.
Publicado: (2015)

C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19
por: Pink, Isabell, et al.
Publicado: (2021)

C-reactive protein-guided use of procalcitonin in COVID-19
por: Houghton, Rebecca, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ri3shvqh3jikd6n8qi72umauc9